Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells
- 30 April 1993
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 30 (6) , 517-519
- https://doi.org/10.1016/0161-5890(93)90025-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Involvement of Prostaglandin-Producing Pathway in the Cytotoxic Action of TUmor Necrosis Factor.Cell Structure and Function, 1991
- Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases.The Journal of Experimental Medicine, 1988
- Resistance of tumor cells to tumor necrosis factorJournal of Clinical Immunology, 1988
- Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.Journal of Clinical Investigation, 1988
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985